Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy

Br J Cancer. 1983 Jun;47(6):797-802. doi: 10.1038/bjc.1983.133.

Abstract

Intravenous injection of Corynebacterium parvum (C. parvum) 4 days after s.c. inoculation of 5 X 10(5) cells derived from the immunogenic fibrosarcoma FSA/R induced tumour growth inhibition over a period of 21 days in syngeneic C3H/Buf mice. This was not accompanied by a change in the proportions of host cells within the tumour, but the activation state of tumour-infiltrating macrophages was increased following C. parvum therapy. Two macrophage subpopulations were identified in FSA/R tumours after fractionation by unit gravity velocity sedimentation. After i.v. C. parvum therapy the tumour-infiltrating macrophage subpopulation which sedimented between 1 and 6 mm h-1 was consistently activated as determined by measurement of Fc receptor avidity. Other intra-tumour macrophages were generally unaffected by C. parvum treatment. We have previously shown that the host cell fraction sedimenting between 1 and 6 mm h-1 is enriched with monocytes and the data presented in this paper suggest that these cells may enter the tumour in a pre-activated state following intravenous C. parvum therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Vaccines / therapeutic use*
  • Cell Separation
  • Centrifugation, Density Gradient
  • Fibrosarcoma / immunology*
  • Fibrosarcoma / therapy
  • Macrophage Activation
  • Macrophages / classification
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Transplantation
  • Propionibacterium acnes / immunology*
  • Receptors, Fc / analysis*
  • Sarcoma, Experimental / immunology*
  • Sarcoma, Experimental / therapy

Substances

  • Bacterial Vaccines
  • Receptors, Fc